Gene Therapy Overview:
Gene therapy is defined as the treatment of disease by transfer of genetic material into cells. This review will explore methods available for gene transfer as well as current and potential applications for craniofacial regeneration, with emphasis on future development and design.
Gene Therapy Drugs: 300+
Gene Therapy Companies: 250+
Key Gene Therapy Companies
- Novartis
- Johnson & Johnson
- Fibrocell Technologies
- Pfizer
- HELIXMITH Co., Ltd.
- Sarepta Therapeutics
- REGENXBIO
- Solid Biosciences Inc.
- Lexeo Therapeutics
- Spark Therapeutics
- Xalud Therapeutics
- uniQure
- Ultragenyx Pharmaceutical
- Nanoscope Therapeutics
- Homology Medicines
- Freeline therapeutics
- Amicus Therapeutics
- REGENXBIO
- Gyroscope Therapeutics
- CSL
- Sangamo Therapeutics
- Spark therapeuics
- LYSOGENE
- Asklepios BioPharmaceutical
- Alcyone Therapeutics
- Taysha Gene Therapies
- Gensight Biologic
- Vivet Therapeutics
- BridgeBio
- And several others.
Gene Therapy Report Assessment
- Company Analysis
- Therapeutic Assessment
- Approved/Pipeline Assessment
- Inactive drugs assessment
- Unmet Needs
Gene Therapy Therapeutic Assessment:
- By Product Type
- By Stage and Product Type
- By Route of Administration
- By Stage and Route of Administration
- By Molecule Type
- By Stage and Molecule Type
Related Reports:
- Adeno-Associated Virus Vectors in Gene Therapy - Market Insight, Epidemiology And Market Forecast - 2032
- Gene Therapy In CNS Disorder - Market Insight, Epidemiology and Market Forecast – 2032
- Cell And Gene Therapy For Multiple Myeloma - Market Insight, Epidemiology And Market Forecast - 2032
- Gene Therapy in Oncology: Innovation to Commercialization, Competitive Landscape, Technological Advancements, Market Opportunities & Future Directions
- Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2022
- Nucleic Acid and Gene Therapies in Neuromuscular Disorders - Market Insight, Epidemiology and Market Forecast – 2032
- Gene Therapies for Cardiomyopathies - Market Insight, Epidemiology And Market Forecast - 2032
- Gene and Cell Therapies Targeting CNS Disorders - Market Insight, Epidemiology And Market Forecast - 2032
- Gene And Cell Therapies In Rare Disorder - Market Insight, Epidemiology And Market Forecast - 2032